Amgen
AMGN
2,717 hedge funds and large institutions have $118B invested in Amgen in 2023 Q4 according to their latest regulatory filings, with 331 funds opening new positions, 978 increasing their positions, 1,050 reducing their positions, and 89 closing their positions.
272% more first-time investments, than exits
New positions opened: 331 | Existing positions closed: 89
47% more capital inflows, than outflows
Capital inflows: $6.27B | Capital outflows: $4.26B
9% more funds holding
Funds holding: 2,499 → 2,717 (+218)
1% more ownership
Funds ownership: 75.84% → 76.84% (+1%)
6% less call options, than puts
Call options by funds: $1.91B | Put options by funds: $2.03B
7% less repeat investments, than reductions
Existing positions increased: 978 | Existing positions reduced: 1,050
10% less funds holding in top 10
Funds holding in top 10: 87 → 78 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$378M |
| 2 |
Neuberger Berman Group
New York
|
+$328M |
| 3 |
Morgan Stanley
New York
|
+$323M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$309M |
| 5 |
State Street
Boston,
Massachusetts
|
+$242M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$487M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$385M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$207M |
| 4 |
Two Sigma Investments
New York
|
-$169M |
| 5 |
VanEck Associates
New York
|
-$163M |
AMGN Hedge Fund Activity: Q4 2023 in Review
2,717 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2023, worth a combined $118B — up 8.6% from $109B a quarter earlier.
Buyers outnumbered sellers: 331 funds opened new AMGN positions and 89 closed out — a net gain of 242 holders — while 978 added to existing stakes and 1,050 trimmed.
The largest buyer was Barclays, adding an estimated $378M. The largest seller was Capital Research Global Investors, cutting an estimated $487M.
- 2,717 institutional investors held Amgen (AMGN) as of Q4 2023, up from 2,499 in Q3 2023.
- Funds reported $118B of Amgen stock for Q4 2023, up 8.6% quarter-over-quarter.
- 331 funds opened new Amgen positions in Q4 2023 and 89 closed out, a net change of +242 holders.
- The largest Amgen buyer in Q4 2023 was Barclays, an estimated $378M added.
- The largest Amgen seller in Q4 2023 was Capital Research Global Investors, an estimated $487M sold.
Based on aggregated 13F filings for Q4 2023.